Scott Gottlieb, the commissioner of the FDA, was subject to skepticism when he came to the job. Pharma and medical device execs supported his nomination, while […]

Celgene spinout Celularity has raised $250M from Celgene, United Therapeutics, Sorrento Therapeutics, Human Longevity, and other venture capitalists.   Dr. Bob Hariri is founder, chairman and […]

Each year, dozens of branded pharmaceutical products lose their patent protections, paving the way for cheaper generics. FiercePharma compiled this report with info from many different […]

The 34,035 votes for Brineura in FiercePharma’s #FierceMadness drug-name contest raised red flags about ballot stuffing. Digging through digital voting records and comparing IP addresses showed […]

Despite pleas for sentencing mercy, Martin Shkreli will spend up to seven years in prison on federal securities fraud charges. U.S. District Judge Kiyo Matsumoto, who […]

U.S. IPO activity has been increasing, with 36 IPOs raising more than $12.7B so far this year according to EY, the global consulting and accounting firm. […]

Elizabeth Holmes, founder and CEO of Theranos, was charged by the Securities and Exchange Commission (SEC) with a massive fraud in which she and former Theranos […]

There were many changes in the pharma industry in 2017 – from the new presidential administration to scrutiny over drug pricing to major scientific advancements like […]